Mixed portfolio movements for Agilent Technologies have recently been reported. While D.A. Davidson & CO. and GATEWAY INVESTMENT ADVISERS LLC have increased their shares, institutions such as M&T Bank Corp, Envestnet Asset Management Inc, and Robeco Schweiz AG have reduced their holdings.Evercore has maintained a Hold rating and raised the target price to $130. Agilent's CEO recently sold 1,508 shares, sparking hesitancy amongst investors.Agilent, with a 90% institutional ownership, remains an institutional favorite.
An impressive collaboration was established with ABB to advance laboratory automation. Their stock value increased by 5.4% since the last earnings report. Their products were recognized at the US and Canadian Conference as well as receiving praise from financial analyst Jim Cramer. A significant earnings report demonstrated strong revenue growth. New digital pathology tools and lab innovations have been unveiled at HPLC 2025 Conference.Agilent's shares were rated Moderate Buy by brokerages, despite some hesitations observed in insider activities.
Agilent Technologies A News Analytics from Mon, 02 Dec 2024 08:00:00 GMT to Sat, 12 Jul 2025 23:25:32 GMT - Rating 2 - Innovation 6 - Information 7 - Rumor -4
